Macarena Pozo-Morales Selected Research

4-(3-3,4-p-menthadien-(1,8)-yl)olivetol

1/2022	Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.
1/2020	The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Macarena Pozo-Morales Research Topics

Disease

2	Fibrosis (Cirrhosis) 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Body Weight (Weight, Body) 01/2022 - 01/2020
1	Starvation 07/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Obesity 01/2020
1	Prediabetic State (Prediabetes) 01/2020

Drug/Important Bio-Agent (IBA)

2	4-(3-3,4-p-menthadien-(1,8)-yl)olivetolIBA 01/2022 - 01/2020
2	CannabinoidsIBA 01/2022 - 01/2020
1	LipidsIBA 07/2022
1	CalciumIBA 07/2022
1	CytokinesIBA 01/2022
1	CannabidiolIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020